Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PD .... based on what you say if AMRN just revised their name to VAscepa-CAD meaning vascepa for CAD - this would prevent all CAD infringement ?
There was a fake 'group' that often wrote about AMRN to destroy the stock does anyone remember their name this was about 3 - 4 years ago
I find this very fascinating this is bottom up information - this confirms the real world experience that is being posted here - formularies are giving into vascepa (as Dukesking so ably posted) - bottom up knowledge is real world experience its value is much more than top learning experience which is theoretical - we can have all the biochemical theories we want - but knowing that formularies will be covering vascepa is a much stronger indicator of SP potential - to me this is some of the best news we have seen in a long time
Great news LIzzy !
I just performed another consultation on upcoming med for diabetes the GLP-1 and SGLT group continues to show reduction in CAD- so much to the point that they are beginning to be prescribed independently of DM2 - it would be interesting to combine vascepa with each of these med groups and then determine cardiac risk reduction - perhaps push into the 40% range
new class of meds dual glucose dependent insulinotropic polypeptide (GIP) AND GLP-I receptor agonist that integrated the actions of BOTH incretins into a single molecule --
I dont mind anyone posting contrarian information - at times this can become an echo chamber - having contrarian views helps to balance the situation - truth welcomes dissent for it helps build the wall of knowledge having said that we all at times find someone annoying - or as the old saying goes " everyone is strange except thee and me and even thee is strange at times ".... and I understand your time issue
so this is what Ihub says to block someone
I'm getting annoying private messages from one of the Posters on the board. I really want to be able to see her posts but I don't want to read this junk. Is there a way to block private messages and still see her posts?
If you are a Subscriber, go to their profile. Click on "Ignore This Poster". Then at the very top of your screen, you should see either "Ignores On" or "Ignores Off". If you only want to block private messages, make sure this says "Ignores Off". You can still see public posts but the Member is unable to send you PMs. If you do not have the Ignores Off/On at the top of your screen, go to "Tools", "My Ignores" and ensure that "Ignores" are "Enabled". If you are not a Subscriber, and you are receiving unwelcome PMs, then you have the option of using the Ignore feature to block private and public posts. (See above regarding using the Ignore feature as a Moderator.)
What I find interesting is that HeALthnet has no gV ...isnt that tacit admission they were doing something wrong ?
This should be brought forward to your States department of health - this type of substitution cannot be legal they are providing a med with absolutely no cardiac benefit - its like ordering penicillin and them giving you zyrtec .... makes no sense
Wow JOhn ...what a read ... rather amazing ... I am disheartened that ARMN's lawyers did not appear to have had competent statistical and scientific analysis and or their lawyers lacked understanding of such ...seems to be legal malpractice.
As for JUdge DU ...she needs to recognize when she has entered an arena she does not have the tools to understand. UNfortunately many people feel that is an intellectual insult. It is not I explain to people that there are many cook books in life - just because you are familiar with one but not another makes you no less or more intelligent. A person who is secure will simply step forward and say - I am not familiar with this arena of knowledge which takes many people at least 4 years of college to acquire. TO believe that i can acquire this specialized knowledge in 4 weeks is just assinin ( yet it appears thats what many judges think) so I will obtain experts to teach and explain tio me the information I need to make a decision. DId JUdge DU retain scientific and statistical experts to help her review this information ? Can that be determined ?
If she didnt isnt that a form of negligence ?
Soon ? ...NOVEMBER 2023 is the trial date ....
Thats only if they win against health net ?
Hilarious ...- so generics have no monetary outlay for research or advertising and can charge 90% of retail and capture the market - not a bad way to make a living - isnt it great when career politicians try to make laws for business !
AMRN nails HIKMA in their infringement suit - clearly citing statements of indications and sales all directly pointing to infringement yet by doing so AMRN lays down a blue print for other generic manufacturers on what not to do ...talk about a losing situation - if you can win you have instructed other how to beat you ...
On information and belief, Health Net, on its own and through its various
subsidiaries, provides insurance coverage for patients in the United States.
87. On December 11, 2020, Amarin sent a letter to the payer community, including
Envolve, the Pharmacy Benefit Manager (“PBM”) that Health Net, on information and belief, uses
to manage its pharmacy benefits, concerning the launch of the Hikma Defendants’ generic version
of VASCEPA®. Ex. GG. In the letter, sent via electronic mail to Mr. Mike Flynn at Envolve
Pharmacy Solutions, Inc. (“Envolve”), who Amarin uses as its point of contact for Health Net,
Amarin explained that the Hikma Defendants’ generic version of VASCEPA® is not FDAapproved for the CV Indication:
Furthermore, Hikma’s generic icosapent ethyl product is indicated
as an adjunct to diet to reduce triglyceride levels in adult patients
with severe (=500 mg/dL) hypertriglyceridemia. Severe (=500
mg/dL) hypertriglyceridemia represents <10% of the overall
utilization of VASCEPA. It is important to note that, unlike the
Hikma generic, VASCEPA is also indicated for cardiovascular (CV)
risk reduction on top of statin therapy. The Hikma generic does not
have an FDA-approved indication for CV risk reduction.
fg2 - interesting can you post that link again does not seem to b working
Yes by all means please tell the APES that not only does AMRN need help but they can help to save lives at the same time --- nothing better than a NOBLE MAGNANIMOUS APE ....
I think they are an insurer ...
BP wont pay more than 100% premium for this dog $8 works for me (in at $4 ) but a lot of people here would get hurt badly
Yes Skipperdog seems ripe for a real Robin Hood vs KIng HIKMA story....
small biotech company risks millions of dollars to perform study to advance cardiac health only to see it stolen while US legal systems turns a blind eye.
KIng HIKMA will not turn any money over to helping his citizens he will not put money into research or education He will only take peasants money to enrich himself
...and AMRN has named NO PBM on the infringement issue ....
NS the last post on HIKMA rx's showed a tremendous increase - if they continue on that trajectory they will eat our lunch - why should AMRN spend $ so HIKMA can make money ..... Id put our efforts into the sure market and secure that first - WHen people die because of JUdge DU - thats on her
Agree skipper dog - I would just cease all marketing lay off reps and wait to see outcome of infringement put all my time and money elsewhere . If they want to spend money how about a commercial that says
IN the US almost 1 million people die of a heart attack each year. A small biotech company researched and developed an amazing drug that could save a quarter of a million people a year. HOwever its rights are being trampled
on by infringing companies who paid zero for this research and are making it impossible for this company to survive in the US The US legal system has turned a blind eye to this situation - for that reason the company has ceased spending any money to educate the public and physicians and as a result a quarter of a million people will die - generic companies who seek only profit will not spend a penny to research or educate patients or physicians
Unfortunately AMRN has been outfoxed at most turns ....
SO far generics are eating AMRN's lunch at what level do they stop eating our lunch ?
I want to ask why but I have come to the conclusion that logic and truth are strangers to US legal system - it appears no better than a third world dog and pony show ... we know infringement is occurring but we cant do a thing about it ....
Always watching - you always make me laugh - when this happens we are all going to respond to you YES !!!
If I were AMRN I wouldn't spend a penny on the US market right now - I Would put all my resources elsewhere until the HIKMA case is settled - lay off all reps until infringement case settled
THEY NEED TO ADD a PBM ...
STS
so lets start this game all over ...ok so they have that on the label and its given out for REDUCE IT indications
who is responsible for the infringement ?
Manufacturer - Pharmacist - Insurer - PBM ?
If AMRN was a patient I would refer it out for indepth counseling and start meds ....many meds ... mostly controlled substances and atypical antipsychotics
From what I recvall trial doesn't start until NOv 2023
NOt silly at all RM... the fact of the matter is we have lost the 10% OF THE MARKET THAT WE DIDN'T REALLY CARE ABOUT- we lost something we didnt want - the only benefit would have been prevention of infringement on the other 90% .
What really matters is the infringement case ... unfortunately that is going to take two more years and HIKMA undoubtedly has been emboldened by these results
Yes KIWI - there are about 10% of people that get myalgias from statins no drug works for everyone - they all have side effects -
Pharmacies are already stocking Crestor 5-10-20 40
Lipitor 10-20-40-80
Vascepa 500 and 1000
SO I have 10 bottles here vs 8 of the combo
Docs could write the Rx's separately - but its more work and we make certain that the Vastor is less costly that the meds written separately
New Ad Idea
Picture 25 faces in a collage
then an ominous boom and an x across a face
Joe died of a heart attack
another boom and an x across a face
so did Henry
another boom and an x across face
so did LInda
then two more
then announcer comes on and says
All five of those people would still be alive ...if they took Vascepa
Its time to go NUCLEAR
Vastor A-10
Vastor A-20
Vastor A-40
Vastor A-80
Vastor R-5
Vastor R-10
Vastor R-20
Vastor R-40
Completely eliminates infringement. They should be marketing concomitantly with Vascepa right now and slowly eliminating Vascepa.
HIKMA didnt respond because they know JUdge DU is wrong - they did not want to defend an error in front of the SC - they basically got caught duping a not so bright judge and my guess in the SC doesnt like such game playing so the safest course was just to say - its already been tried and appealed - 4 judges can't be wrong ....
Agree Rob777 - people love to help an underdog...AMRN should be singing the blues about how they are being squashed by big pharma and big medical. How the esteemed Cleveland clinic is acting more like a hitman for big pharma than an academic institution ...etc etc
This is true but the more we reveal that his actions are not based upon science the more we reveal his obfuscation for personal shortcomings
Great news oneragman thanks for your insight !!